_id
691058a6ccc777a4e85d5705
Ticker
CYRX
Name
Cryoport Inc
Exchange
NASDAQ
Address
112 Westwood Place, Brentwood, TN, United States, 37027
Country
USA
Sector
Industrials
Industry
Integrated Freight & Logistics
Currency
USD
Website
https://www.cryoportinc.com
Description
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and cryogenic biostorage within the life science industry. Its Life Sciences Products segment offers cryogenic freezers, cryogenic dewars, and accessories within the life science industry through direct sales or a distribution network. The company's products include Cryoport Express Shippers; Cryoport ELITE Shippers; Cryoport Express Cryogenic HV3 Shipping System; Smartpak II Condition Monitoring System and Tec4Med; and Cryoport accessories. It also provides Cryoport BioStorage/Bioservices, such as CRYOGENE, a biostorage solution for the provision of pre-clinical temperature-controlled biological materials management services; and Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release. In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; CRYOPDP, a temperature-controlled logistics solution; MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; and Vario cryogenic system, a cryogenic freezer system. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. The company was founded in 1999 and is based in Brentwood, Tennessee.
Last Close
9.64
Volume
265628
Current Price
9.35
Change
-3.0082987551867313
Last Updated
2025-11-29T12:05:44.154Z
Image
data:image/webp;base64,UklGRs4JAABXRUJQVlA4WAoAAAAQAAAAPwAAPwAAQUxQSG0GAAANmQssRPQ/1mS3/X83lp33nrz33nvvGpD6DwV47733XgqGwxluBb9os4PNLtjFgh1sNpguiM2Ef6TsD2ULhgqVDdgFJ3wdEJs9nAr+2OyCVQwmUwmDm20HBwrvCV+obMAOFA6YvQ6I28XBZouTqYMBuyCYKVRG3PAiYgIm4JGY5/M833M8Bn/ye39gzG85BrvUGGcYutvmuBYf9XS/811/BgEJgQBoEEgIAjHGU2Q+7+iXUmP+iJ/G0jMIAaStJWtZmZ/7lV/DT7yAjeaZtqKUM9JphBYCa01xHDN+qswi8K9id8UP/Aa9iEVYUSUA6Gd5tpfStv2h4uE3vUSt50PZc7HZtdXLYL7c2iZGlsUe7ITmYZsL81U/wxcec1creN1Bp9/Xn2GO+oV02RaDRqSu969Q+7IzNIeqydNPUA2i3X8HqtH47A1OMbtudNpXHaJNT5F3ldoJY3a93I6fktSIdnfA8r3wZsX5ppcXy2w4GnT7C0mNiFvkw2vd26dKjIy1xEaIpmQX5SdlNaI21Rsth9PPaF/ugnffFr/PWW8G1gE+ca3rMLOARRNBE4kC+MdslY8LWeMiTb4E3sY6tQh8IF+2axBetSw9WZuRaNGZj5n8qIqbpamBH7lcrG1pX634GgnIfNoPCM2mt2SJrBciECtnyNYJaJFKYoDzbqnrOMtIlRlgt7uCdZj0cE5D1XkiZiOAUiVU1eSX5VO7XX0xbtzN/X9G7ZwMaa+ARvrxAtNl7K33Wa1HQaCIiEHaNojtoWzTrjr4uhkPZSWJ2R1AtTqt/bTiG2TZnFULh+kEQFS7v3rQLddfkT5eoxvy6sHHHdb60n2BgicePab2pbVdbQSzErDnNmZkWTkmMW3e6rDLYTNnsR13pUawuvk99TttxxJzvRQw8DbmlOJ84M9Z7e/BKJWY/KR1yyA5pSHp3Ig5EwCd0eAs78xe3QNkTbWr2SkboPY31x+Tu81BhvlMclu/xS06OuMGAFrnCVukCQJvyvpsS/1BBPMXGm2mfU6YFGVikCgdcDjZflRysv+8k+tjBNj7Gx3VDpOiJR1YIbhI6+WZPXm4ikdESPuxqJayDyDRzGRgJ+Rx/x5nZ4e/X13vEOll329eTyOYABZDNNFKdbntT3aSm2jQbZyqgkgABQcNYFes1x/BnzWuKisRWe9Na9WEABAYxAAWdrnk9rCtc0RNO3KWMJ2RkgDqvHqN5OEiwbYqo4LXykgIBQcCSp111df1uug8ohMmhGRiAGYcthh7gxwskZEGUwhhAGh91SkzZoAllqg0mCQEwNAQdJLumKABiYwIrAEhEgACBw9BhjIFAG+Vi8ozCwCCAAAjJU9E2pepB3RmTXkNaIRUMBBvNVWGCRDv2Uk05JVJAJAEsDjAZl4ZAQEq9sIqGhubEgAEgQIDTdYqVmIBsI59G02nHE9MZRiCJREWEADFzTbto2iyTUuhHLGQWK8M2BNQ2LyjhcyPtuVC1aJlCh8EAHltSqW1BVwxnIEP82ssNq8EEi1BqSaL0cSVMAtZAKXoJlEHmQ9tfdFuCSAEqyKmRO1X+eABpQFAju2tW+PpYj7b2+l/dQ4QU1DBua4wpgTWTsgCQOGyJK/NQWajxqdF+S8AohGc+owbVqUpIKaM4wksVul7XafDeT9Lk/vdk+YSkxLkTqr8SDb2qwJaMTRNyIqrbdLFaa9kGtkuMyj0XQqYusgqEtDtCxFoESV+Anw8Xdy6/jpnatUXRmlN3lbWrdpjkyP8sbxbOwCESYIpkwDgUOqsqytvLQgAU+lN6h4QwvO3VLkoTLfU7/wyCMX9hza/9yZ3h9oKlDhjRGrMutG+eYiQuRtbJFOAdCM+tpaIGMrmmONKbfMjwup8URDV0+A2d+7sjACE+aZX1fulJhRi7Yo0iadNKqcYcy77LIlbhKdtdf8q/1u4CNP72f+HvcyABu0ipeGaSBdxPdxhzEpLa/53dfHvGYRAMtPxL9m7bVeM2XWDxWGMh3AECGZUG8ry7Sljns1FuXnqav0PH2aqEEnQ8Qmb/zU+MuZb5ao4tGpZhSAJIAggWtyirOI8bQXzPrtbrj7tn3T3RjNFECQAeFXeiW83zbFEhFXO6aJNy3gZB0wVgNNCfFzn6hzRLm8k+ouefGIlw1mT1LFmCCsWxQcdJ3VCxiFqu7bGlIqFiSCESQGJhvbqKJgZAFZQOCA6AwAA0BEAnQEqQABAAD6tSp5JpiSjIS4W3jDAFYlsAL4JQX5nyM05e0ebRVn8F+H94TMHDo26fmJ6EXoAf0PqIfQA8uP9lfgt/cn0oHz8yojLHoAdCv9qvYA/TNPuMEPyJOrhWCTHrJcrayptlEekM686A6xihHXEAgUcM+qZD9ciX/bTNzB47pmvasxX4XWzG2D7SZl3iPDTAAD+/hldvJx9aSsTrgy2F66GUFO3hxuFhUhiRXyp4FdfBr/jqf7EWvFpcs+ynGVPXPlmo9IsdOoAR7GU7af9NiiFPEQXTbCRiyceUDTqcNcThvO0IabPMl2eb5xyzf1WZg6MudE3g+Q2bH8FsDHS5TqE/2UwrypCz/6wj+lw8m2RGr2vPoPfZ+BTY08TMUM2VFrL6dXPcBPTznCzN7gm+SqJlA+73pnI2cUwdfMn4YRjVMYjJogNpV7ZsVdhWGtGNaWvi6od893snDUgiJPWmUZNC4I/2uS/fyr04Kh2mpvOL/5Y3cQkCH8xYqPpHQ3B/JyURY5wpFtC5RBxv8zKenKflayOZ7QY22pv1LLK5ePfxkIiB7/9kQkaM9omxj7em6X6XYfa/8bahPODB0gCGFIUpkl6/mKLHZca3mUNfl8LbSHFrV9fDt+0NOXx8xEIV7erJBuSvZchTvUliYdHCCX7izqEF2kOWLYU/AKIMPZF1emX52Of/E47DT9HOgawDYvigePqALMltK8JQAXQ6x3sy0SbEdsauroRfk1hpSyztMnu1DDUBqC2XvX38/6JT6IWR2yF84cSZ63ELPqBiwvbVFjy6NPD5+ZDin8uSv8KVJrn3dPR3Tj+chVYgQAhA/29xBp7VhvO0r1YtkKKWqyNRSIV3u47Ab4mMHPhiT3e63//KuiQIQwRBLUDYZrOMU70J44oDsIi07vrn8y+2fjznBsvPJy1NVl3yfTjz1cMV+4kCItELvvty4QyZOTGrOycNg6C72lX6zoUrmk/vavpwu1tY7qAIomyEKtF1wFIsq6FgaqJtSJl1U6ZHJ3aeT7V92tJL9sW4Gla5nTZ8nxFLbHukgja5p/041t3aFxe1fKTteIkt31FsiXtsXO30XAAAA==
Ipo Date
2005-03-15T00:00:00.000Z
Market Cap
481662848
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9986666666666667
Sentiment Sources
3
Rating
4
Target Price
13.2222
Strong Buy
4
Buy
2
Hold
4
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
44233000
Cost Of Revenue
22908000
Gross Profit
21325000
Operating Expenses
31257000
Operating Income
-9932000
Interest Expense
526000
Pretax Income
-6531000
Net Income
-6943000
Eps
-0.13851297513262173
Dividends Per Share
-
Shares Outstanding
50068904
Income Tax Expense
165000
EBITDA
410000
Operating Margin
-22.453824068003527
Total Other Income Expense Net
3401000
Cash
243416000
Short Term Investments
182559000
Receivables
33409000
Inventories
23035000
Total Current Assets
489490000
Property Plant Equipment
119771000
Total Assets
773927000
Payables
14756000
Short Term Debt
4316000
Long Term Debt
186090000
Total Liabilities
258536000
Equity
515391000
Depreciation
6415000
Change In Working Capital
-1018999
Cash From Operations
2188000
Capital Expenditures
3453000
Cash From Investing
14306000
Cash From Financing
-2868000
Net Change In Cash
12395000
PE
-
PB
0.9521438552865688
ROE
-1.3471325653726975
ROA
-0.8971130352087471
FCF
-1265000
Fcf Percent
-0.028598557637962606
Piotroski FScore
2
Health Score
31
Deep Value Investing Score
6
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
2
Growth Investing Score
1.5
Momentum Investing Score
6
Net Net Investing Score
2
Quality Investing Score
2.5
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
44233000
Quarters > 0 > income Statement > cost Of Revenue
22908000
Quarters > 0 > income Statement > gross Profit
21325000
Quarters > 0 > income Statement > operating Expenses
31257000
Quarters > 0 > income Statement > operating Income
-9932000
Quarters > 0 > income Statement > interest Expense
526000
Quarters > 0 > income Statement > pretax Income
-6531000
Quarters > 0 > income Statement > net Income
-6943000
Quarters > 0 > income Statement > eps
-0.13851297513262173
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
50125268
Quarters > 0 > income Statement > income Tax Expense
165000
Quarters > 0 > income Statement > EBITDA
410000
Quarters > 0 > income Statement > operating Margin
-22.453824068003527
Quarters > 0 > income Statement > total Other Income Expense Net
3401000
Quarters > 0 > balance Sheet > cash
243416000
Quarters > 0 > balance Sheet > short Term Investments
182559000
Quarters > 0 > balance Sheet > receivables
33409000
Quarters > 0 > balance Sheet > inventories
23035000
Quarters > 0 > balance Sheet > total Current Assets
489490000
Quarters > 0 > balance Sheet > property Plant Equipment
119771000
Quarters > 0 > balance Sheet > total Assets
773927000
Quarters > 0 > balance Sheet > payables
14756000
Quarters > 0 > balance Sheet > short Term Debt
4316000
Quarters > 0 > balance Sheet > long Term Debt
186090000
Quarters > 0 > balance Sheet > total Liabilities
258536000
Quarters > 0 > balance Sheet > equity
515391000
Quarters > 0 > cash Flow > net Income
-6696000
Quarters > 0 > cash Flow > depreciation
6415000
Quarters > 0 > cash Flow > change In Working Capital
-1018999
Quarters > 0 > cash Flow > cash From Operations
2188000
Quarters > 0 > cash Flow > capital Expenditures
3453000
Quarters > 0 > cash Flow > cash From Investing
14306000
Quarters > 0 > cash Flow > cash From Financing
-2868000
Quarters > 0 > cash Flow > net Change In Cash
12395000
Quarters > 0 > ratios > PE
-0.13851297513262173
Quarters > 0 > ratios > PB
0.9521438552865688
Quarters > 0 > ratios > ROE
-1.3471325653726975
Quarters > 0 > ratios > ROA
-0.8971130352087471
Quarters > 0 > ratios > FCF
-1265000
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
-0.028598557637962606
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
45454000
Quarters > 1 > income Statement > cost Of Revenue
24077000
Quarters > 1 > income Statement > gross Profit
21377000
Quarters > 1 > income Statement > operating Expenses
31026000
Quarters > 1 > income Statement > operating Income
-9649000
Quarters > 1 > income Statement > interest Expense
618000
Quarters > 1 > income Statement > pretax Income
-11740000
Quarters > 1 > income Statement > net Income
105180000
Quarters > 1 > income Statement > eps
2.092838124084806
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
50257112
Quarters > 1 > income Statement > income Tax Expense
274000
Quarters > 1 > income Statement > EBITDA
-3826000
Quarters > 1 > income Statement > operating Margin
-21.22805473665684
Quarters > 1 > income Statement > total Other Income Expense Net
-2091000
Quarters > 1 > balance Sheet > cash
36102000
Quarters > 1 > balance Sheet > short Term Investments
207929000
Quarters > 1 > balance Sheet > receivables
28371000
Quarters > 1 > balance Sheet > inventories
23340000
Quarters > 1 > balance Sheet > total Current Assets
411276000
Quarters > 1 > balance Sheet > property Plant Equipment
119583000
Quarters > 1 > balance Sheet > total Assets
699844000
Quarters > 1 > balance Sheet > payables
13442000
Quarters > 1 > balance Sheet > short Term Debt
18476000
Quarters > 1 > balance Sheet > long Term Debt
185832000
Quarters > 1 > balance Sheet > total Liabilities
301033000
Quarters > 1 > balance Sheet > equity
398811000
Quarters > 1 > cash Flow > net Income
-11981000
Quarters > 1 > cash Flow > depreciation
7296000
Quarters > 1 > cash Flow > change In Working Capital
-10133000
Quarters > 1 > cash Flow > cash From Operations
-7345000
Quarters > 1 > cash Flow > capital Expenditures
4351000
Quarters > 1 > cash Flow > cash From Investing
230039000
Quarters > 1 > cash Flow > cash From Financing
-15864000
Quarters > 1 > cash Flow > net Change In Cash
207314000
Quarters > 1 > ratios > PE
2.092838124084806
Quarters > 1 > ratios > PB
1.2337100192321675
Quarters > 1 > ratios > ROE
26.373394916388964
Quarters > 1 > ratios > ROA
15.029063619892433
Quarters > 1 > ratios > FCF
-11696000
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-0.2573150877810534
Quarters > 1 > health Score
70
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
41040000
Quarters > 2 > income Statement > cost Of Revenue
22399000
Quarters > 2 > income Statement > gross Profit
18641000
Quarters > 2 > income Statement > operating Expenses
28125000
Quarters > 2 > income Statement > operating Income
-9484000
Quarters > 2 > income Statement > interest Expense
583000
Quarters > 2 > income Statement > pretax Income
-8794000
Quarters > 2 > income Statement > net Income
-11981000
Quarters > 2 > income Statement > eps
-0.23987420909182716
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
49947012
Quarters > 2 > income Statement > income Tax Expense
234000
Quarters > 2 > income Statement > EBITDA
-565000
Quarters > 2 > income Statement > operating Margin
-23.10916179337232
Quarters > 2 > income Statement > total Other Income Expense Net
690000
Quarters > 2 > balance Sheet > cash
36102000
Quarters > 2 > balance Sheet > short Term Investments
207929000
Quarters > 2 > balance Sheet > receivables
28371000
Quarters > 2 > balance Sheet > inventories
23340000
Quarters > 2 > balance Sheet > total Current Assets
411276000
Quarters > 2 > balance Sheet > property Plant Equipment
119583000
Quarters > 2 > balance Sheet > total Assets
699844000
Quarters > 2 > balance Sheet > payables
13442000
Quarters > 2 > balance Sheet > short Term Debt
18476000
Quarters > 2 > balance Sheet > long Term Debt
185333000
Quarters > 2 > balance Sheet > total Liabilities
301033000
Quarters > 2 > balance Sheet > equity
398811000
Quarters > 2 > cash Flow > net Income
-11981000
Quarters > 2 > cash Flow > depreciation
7646000
Quarters > 2 > cash Flow > change In Working Capital
-1065000
Quarters > 2 > cash Flow > cash From Operations
-4342000
Quarters > 2 > cash Flow > capital Expenditures
4078000
Quarters > 2 > cash Flow > cash From Investing
5922000
Quarters > 2 > cash Flow > cash From Financing
-189000
Quarters > 2 > cash Flow > net Change In Cash
-9187000
Quarters > 2 > ratios > PE
-0.23987420909182716
Quarters > 2 > ratios > PB
1.2260976940956994
Quarters > 2 > ratios > ROE
-3.0041799248265466
Quarters > 2 > ratios > ROA
-1.7119529495144632
Quarters > 2 > ratios > FCF
-8420000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.20516569200779727
Quarters > 2 > health Score
31
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
59532000
Quarters > 3 > income Statement > cost Of Revenue
32251000
Quarters > 3 > income Statement > gross Profit
27281000
Quarters > 3 > income Statement > operating Expenses
41212000
Quarters > 3 > income Statement > operating Income
-13931000
Quarters > 3 > income Statement > interest Expense
636000
Quarters > 3 > income Statement > pretax Income
-18648000
Quarters > 3 > income Statement > net Income
-18677000
Quarters > 3 > income Statement > eps
-0.37642487507156347
Quarters > 3 > income Statement > dividends Per Share
6000000
Quarters > 3 > income Statement > shares Outstanding
49616806
Quarters > 3 > income Statement > income Tax Expense
29000
Quarters > 3 > income Statement > EBITDA
-10118000
Quarters > 3 > income Statement > operating Margin
-23.400860041658266
Quarters > 3 > income Statement > total Other Income Expense Net
-4717000
Quarters > 3 > balance Sheet > cash
45289000
Quarters > 3 > balance Sheet > short Term Investments
216460000
Quarters > 3 > balance Sheet > receivables
45778000
Quarters > 3 > balance Sheet > inventories
22470000
Quarters > 3 > balance Sheet > total Current Assets
341571000
Quarters > 3 > balance Sheet > property Plant Equipment
136027000
Quarters > 3 > balance Sheet > total Assets
703492000
Quarters > 3 > balance Sheet > payables
26168000
Quarters > 3 > balance Sheet > short Term Debt
20348000
Quarters > 3 > balance Sheet > long Term Debt
185033000
Quarters > 3 > balance Sheet > total Liabilities
301594000
Quarters > 3 > balance Sheet > equity
401898000
Quarters > 3 > cash Flow > net Income
-18677000
Quarters > 3 > cash Flow > depreciation
7894000
Quarters > 3 > cash Flow > change In Working Capital
-2804000
Quarters > 3 > cash Flow > cash From Operations
-5480000
Quarters > 3 > cash Flow > capital Expenditures
5641000
Quarters > 3 > cash Flow > cash From Investing
3479000
Quarters > 3 > cash Flow > cash From Financing
2012000
Quarters > 3 > cash Flow > net Change In Cash
624000
Quarters > 3 > ratios > PE
-0.37642487507156347
Quarters > 3 > ratios > PB
1.208636347381674
Quarters > 3 > ratios > ROE
-4.647199040552578
Quarters > 3 > ratios > ROA
-2.6548987053157678
Quarters > 3 > ratios > FCF
-11121000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.1868070953436807
Quarters > 3 > health Score
31
Valuation > metrics > PE
-0.13851297513262173
Valuation > metrics > PB
0.9521438552865688
Valuation > final Score
70
Valuation > verdict
4.8% Undervalued
Profitability > metrics > ROE
-1.3471325653726975
Profitability > metrics > ROA
-1.4184150850885615
Profitability > metrics > Net Margin
-0.1569642574548414
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.5016308006930661
Risk > metrics > Interest Coverage
-18.88212927756654
Risk > final Score
-28
Risk > verdict
High
Liquidity > metrics > Current Ratio
25.66537332214765
Liquidity > metrics > Quick Ratio
24.457581795302012
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
100
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
100
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-14
Prev Risks > 1
-17
Prev Risks > 2
-40
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-12T15:54:44.728Z
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and cryogenic biostorage within the life science industry. Its Life Sciences Products segment offers cryogenic freezers, cryogenic dewars, and accessories within the life science industry through direct sales or a distribution network. The company's products include Cryoport Express Shippers; Cryoport ELITE Shippers; Cryoport Express Cryogenic HV3 Shipping System; Smartpak II Condition Monitoring System and Tec4Med; and Cryoport accessories. It also provides Cryoport BioStorage/Bioservices, such as CRYOGENE, a biostorage solution for the provision of pre-clinical temperature-controlled biological materials management services; and Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release. In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; CRYOPDP, a temperature-controlled logistics solution; MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; and Vario cryogenic system, a cryogenic freezer system. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. The company was founded in 1999 and is based in Brentwood, Tennessee.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AA new trading data show CryoPort Inc (CYRX) is showing positive returns. setenews.com
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$13.2222
Analyst Picks
Strong Buy
4
Buy
2
Hold
4
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 103.15% of the total shares of Cryoport Inc
1.
Cadian Capital Management LP(9.9252%)
since
2025/06/30
2.
Morgan Stanley - Brokerage Accounts(9.136%)
since
2025/06/30
3.
BlackRock Inc(8.2278%)
since
2025/06/30
4.
Brown Capital Management, LLC(7.5878%)
since
2025/06/30
5.
Vanguard Group Inc(5.5695%)
since
2025/06/30
6.
Fred Alger Management, LLC(4.7116%)
since
2025/06/30
7.
Millennium Management LLC(4.4192%)
since
2025/06/30
8.
Thematics Asset Management(3.8246%)
since
2025/06/30
9.
Alger Small Cap Focus Composite(3.4081%)
since
2025/06/30
10.
Alger Small Cap Focus I(3.4081%)
since
2025/06/30
11.
Vanguard Total Stock Mkt Idx Inv(2.8807%)
since
2025/07/31
12.
Thematics Safety I/A USD(2.8061%)
since
2024/12/31
13.
Geode Capital Management, LLC(2.4029%)
since
2025/06/30
14.
iShares Russell 2000 ETF(2.3511%)
since
2025/08/31
15.
New York State Common Retirement Fund(2.288%)
since
2025/06/30
16.
Assenagon Asset Management SA(2.1781%)
since
2025/06/30
17.
Brown Capital Mgmt Small Co Inv(2.1717%)
since
2025/03/31
18.
Deutsche Bank AG(1.9758%)
since
2025/06/30
19.
State Street Corp(1.8804%)
since
2025/06/30
20.
Xtrackers S&P 500 Swap ETF 1C(1.7141%)
since
2025/07/31
21.
Dimensional Fund Advisors, Inc.(1.6713%)
since
2025/06/30
22.
Silvercrest Asset Management Group LLC(1.4753%)
since
2025/06/30
23.
AXA SA(1.4697%)
since
2025/06/30
24.
AXA Framlington Health Fund - R Income(1.4697%)
since
2025/07/31
25.
UBS Group AG(1.2501%)
since
2025/06/30
26.
Edinburgh Worldwide Ord(1.1651%)
since
2025/06/30
27.
Kennedy Capital Management Inc(1.0933%)
since
2025/06/30
28.
Vanguard Institutional Extnd Mkt Idx Tr(1.0822%)
since
2025/07/31
29.
Coeli Circulus Am Micro & Sm Cp I FdrSek(1.0501%)
since
2025/08/31
30.
Fidelity Small Cap Index(0.9783%)
since
2025/06/30
31.
Readystate Asset Management LP(0.969%)
since
2025/06/30
32.
Blackstone Inc(0.9056%)
since
2025/06/30
33.
Kennedy Micro Cap(0.898%)
since
2025/06/30
34.
Invesco Technology S&P US Sel Sec ETF(0.7703%)
since
2025/07/31
35.
Baillie Gifford Global Discovery A Acc(0.7569%)
since
2025/07/31
36.
Franklin US Small Cap Growth Equity(0.6995%)
since
2025/06/30
37.
Brown Capital Small Company(0.6689%)
since
2025/06/30
38.
iShares Russell 2000 Value ETF(0.659%)
since
2025/08/31
39.
Franklin Small Cap Growth Adv(0.6476%)
since
2025/07/31
40.
Thematics Meta I/A USD(0.5994%)
since
2024/12/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.